Zilkha Neurogenetic Institute
About the Institute
The Zilkha Neurogenetic Institute (ZNI) is one of the Centers of Excellence at the Keck School of Medicine of USC. Established in 2003 with a gift from Selim Zilkha, the Zilkha Neurogenetic Institute is a world leader for basic neuroscience research, with a multi-disciplinary team of outstanding faculty whose collaboration concentrates on the causes, effects of and therapies for neurodegenerative disease and psychiatric disorders.
Students work with world leading researchers in various disciplines to conduct world-class bench science with some clinical applications and translational work to investigate and identify the underlying circuitry or mechanisms of the brain that are influenced or affected by neurodegenerative conditions such as Alzheimer’s, Huntington’s disease, schizophrenia, autism, Down Syndrome and hearing and visual disorders. The research experience takes place in a vibrant and dynamic community with access to a variety of state-of-the-art labs and numerous resources.
Hope for reversing stroke-induced long-term disabilityA human protein combined with stem cell therapy has been found to repair stroke damage to the brain, according to a new USC-led study on mice. Permanent brain damage from a stroke may be reversible thanks to a developing therapeutic technique, a USC-led study has found. The novel approach combines transplanted human stem cells with
View All ZNI Events